EPAT: Estrogen in the Prevention of Atherosclerosis Trial

NCT00115024 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

222

Enrollment

NIH

Sponsor class

Conditions

Atherosclerosis
Postmenopause

Interventions

DRUG: Micronized 17B-estradiol

Sponsor

National Institute on Aging (NIA)

Collaborators

[object Object]